SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011140
Filing Date
2023-06-15
Accepted
2023-06-15 16:30:19
Documents
12
Period of Report
2023-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20230614x8k.htm   iXBRL 8-K 52327
  Complete submission text file 0001558370-23-011140.txt   174320

Data Files

Seq Description Document Type Size
2 EX-101.SCH tgtx-20230614.xsd EX-101.SCH 3440
3 EX-101.LAB tgtx-20230614_lab.xml EX-101.LAB 16023
4 EX-101.PRE tgtx-20230614_pre.xml EX-101.PRE 11021
6 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20230614x8k_htm.xml XML 4837
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 231017790
SIC: 2834 Pharmaceutical Preparations